Democratic Republic of the Congo Declares Ebola Virus Outbreak
On Sept. 4, 2025, Health authorities in the Democratic Republic of the Congo have declared an outbreak of…
Biological ‘moonshot’ accelerates efforts to genetically map life on earth
On Sept. 4, 2025, a global collaboration that includes experts at the Wellcome Sanger Institute announced mapping out…
Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina
On Sept. 4, 2025, Revvity announced the opening of its new In Vivo Imaging Center of Excellence in…
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
On Sept. 4, 2025, Novavax announced a milestone payment from Takeda has been triggered by regulatory approval for Novavax’s…
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | NIH | Vaccine | Women's Health
California, Oregon, and Washington to launch new West Coast Health Alliance to uphold scientific integrity in public health as Trump destroys CDC’s credibility
On Sept. 3, 2025, California Governor Gavin Newsom, Oregon Governor Tina Kotek, and Washington Governor Bob Ferguson announced…
Complete brain activity map revealed for the first time
On Sept. 3, 2025, The International Brain Laboratory (IBL) researchers published their findings today in two papers in Nature, revealing…
Golden Goose Award Honors Federally Funded Breakthroughs in Cancer Treatments and Disease Diagnostics
On Sept. 3, 2025, The Golden Goose Award, which spotlights obscure, silly sounding or odd fundamental discovery research that…
C2N Diagnostics Expands St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
On Sept. 3, 2025, C2N Diagnostics (C2N), a specialty diagnostics company announce that its early achievements while based…
Avian flu found in North Dakota, South Dakota turkeys
On Sept. 3, 2025, Avian flu has hit turkey farms in North Dakota and South Dakota, the first…
Navy base in Italy reports case of West Nile virus
On Sept. 3, 2025, Navy hospital here is warning people to take precautions against West Nile virus after…
Amgen to Invest $600 Million in New State-of-the-Art Center for Science Innovation at U.S. Headquarters
On Sept. 2, 2025, Amgen announced plans to invest more than $600 million in a new, state-of-the-art center…
OMass Therapeutics announces Collaboration and License Agreement for IBD with Genentech Worth $420 Million
On Sept. 2, 2025, OMass Therapeutics announces an exclusive collaboration and license agreement with Genentech, a member of…
Biotechnology | NIH | Vaccine
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS®, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
On Sept. 2, 2025, Emergent BioSolutions announced it had received a $30 million contract modification from the Biomedical Advanced…
Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement
On Sept. 2, 2025, Arrowhead Pharmaceuticals announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, Arrowhead’s…
Biotechnology | Diagnostics | Disease | Neurology | Oncology
New genetic biomarker flags aggressive brain tumors
On Sept. 1, 2025, a multi-institutional study suggests that typically classifiication of meningiomas by appearances may be deceiving…
Artificial Intelligence | Biotechnology | Diagnostics | Genomics | Infectious Disease | Influenza | Vaccine
MIT researchers develop AI tool to improve flu vaccine strain selection
On Aug. 28, 2025, scientists at MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and the MIT Abdul…
Teva Announces FDA Approval and Launch of Saxenda® – First Generic GLP-1 Indicated for Weight Loss
On Aug. 28, 2025, Teva Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch…
CDC | COVID-19 | Infectious Disease | Influenza | Measles | NIH | Non-Profit Research | U.S. Congress | Vaccine | Women's Health
U.S. CDC chief exits after weeks in role, three top officials resign
On Aug. 27, 2025, the U.S. Centers for Disease Control and Prevention (CDC) Director Susan Monarez has left…
Novavax’s Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
On Aug. 27, 2025, Novavax announced that the U.S. Food and Drug Administration (FDA) has approved the Nuvaxovid™ 2025-2026…
researchers solve 1,500-year-old mystery: The bacterium behind the first pandemic
On Aug. 27, 2025, for the first time an interdisciplinary team at the University of South Florida (USF)…
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64
On Aug. 27, 2025, Pfizer and BioNTech announced the U.S. Food and Drug Administration (FDA) has approved the…
Mexico reports 53% increase in flesh-eating screwworm cases since July
On Aug. 27, 2025, Mexico has recorded 5,086 cases of flesh-eating screwworm in animals as of August 17,…
Artificial Intelligence | Biotechnology | Genomics | Nanotechnology | Neurology | Non-Profit Research
Microsoft co-founder Paul Allen’s final act: New $3.1B foundation bets big on science and tech
On Aug. 27, 2025, a new fun created by Allen’s estate under the late Microsoft co-founder’s instructions, was…
new resource, MacroMap, provides a rich dataset that researchers can use to explore genetic mechanisms behind complex diseases
On Aug. 27, 2025, scientists from the Wellcome Sanger Institute reveal insights into how our genes influence the…
Aedes aegypti non-native mosquito detected in Oregon
On Aug. 26, 2025, health officials in Ashland, Oregon reported that six Aedes aegypti mosquitoes were found in…
Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparedness
On Aug. 26, 2025, Osivax announced it has secured $19.5 million in funding from the Biomedical Advanced Research…
Valneva shares tumble after suspension of U.S. chikungunya vaccine license
On Aug. 25, 2025, shares of French drugmaker Valneva slumped more than 20% after the U.S. Food and…
AbbVie to Acquire Gilgamesh Pharma’s Investigational Therapy for Major Depressive Disorder for $1.2 Billion
On Aug. 25, 2025, AbbVie and Gilgamesh Pharmaceuticals announced a definitive agreement under which AbbVie will acquire Gilgamesh’s…
In a first, pig lung survives and functions—briefly—in a person
On Aug. 25, 2025, in a small step forward for the long-struggling field of xenotransplantation, surgeons in China…
Genentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North Carolina
On Aug. 25, 2025, Genentech, a member of the Roche Group broke ground on its newest U.S. manufacturing site…